Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Equity Line of Credit Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Equity Line of Credit Agreement

Entities:

Nastech Pharmaceutical Co. Inc.; Epstein Becker & Green; Castlebar Enterprises Limited

Date:

2000

Size:

Preview shows 17KB of 92KB total

Price:

$57

ID:

#309009

 

 

► Loans ► Line of Credit ► Equity Line of Credit Agreements
► Services ► Legal
► Biotech & Drugs ► Pharmaceutical Preparations

 

 

Start of Preview


                         EQUITY LINE OF CREDIT AGREEMENT


Between

Nastech Pharmaceutical Company Inc.

And

Castlebar Enterprises Limited

EQUITY LINE OF CREDIT AGREEMENT dated as of July 11, 2000 (the
"Agreement"), between Castlebar Enterprises Limited, a British Virgin Islands
corporation (the "Investor") and Nastech Pharmaceutical Company Inc., a
corporation organized and existing under the laws of the State of Delaware (the
"Company").

WHEREAS, the parties desire that, upon the terms and subject to the
conditions contained herein, the Company shall issue and sell to Investor from
time to time as provided herein, and Investor shall purchase, up to 1,200,000
shares (the "Aggregate Purchase Price") of the Common Stock (as defined below);
and

WHEREAS, such investments will be made by the Investor as statutory
underwriter of a registered indirect primary offering of such Common Stock by
the Company.

NOW, THEREFORE, the parties hereto agree as follows:

ARTICLE I

Certain Definitions

Section 1.1 "Bid Price" shall mean the closing bid price (as reported by
Bloomberg L.P.) of the Common Stock on the Principal Market on the date in
question.

Section 1.2 "Capital Shares" shall mean the Common Stock and any shares of
any other class of common stock whether now or hereafter authorized, having the
right to participate in the distribution of earnings and assets of the Company.

Section 1.3 "Capital Shares Equivalents" shall mean any securities,
rights, or obligations that are convertible into or exchangeable for or give any
right to subscribe for any Capital Shares of the Company or any warrants,
options or other rights to subscribe for or purchase Capital Shares or any such
convertible or exchangeable securities.

Section 1.4 "Commitment Amount" shall mean the dollar amount necessary
which the Investor has agreed to provide to the Company in order to purchase up
to 1,200,000 Put Shares pursuant to the terms and conditions of this Agreement.

Section 1.5 "Commitment Period" shall mean the period commencing on the
Effective Date and expiring on the earliest to occur of (x) the date on which
the Investor shall have purchased 1,200,000 Put Shares pursuant to this
Agreement, (y) the date this Agreement is terminated pursuant to Section 2.3,


1
{PAGE}

(z) the date occurring thirty-six (36) months from the date of commencement of
the Commitment Period.

Section 1.6 "Common Stock" shall mean the Company's common stock, par
value $0.006 per share.

Section 1.7 "Condition Satisfaction Date" shall have the meaning set forth
in Section 7.2.

Section 1.8 "Effective Date" shall mean the date on which the SEC first
declares effective a Registration Statement registering the sale by the Company
and resale by the Investor of the Registrable Securities as set forth in Section
7.2(f).

Section 1.9 "Escrow Agent" shall mean the escrow agent designated in the
Escrow Agreement.

Section 1.10 "Escrow Agreement" shall mean the escrow agreement in the
form attached hereto as Exhibit A.

Section 1.11 "Exchange Act" shall mean the Securities Exchange Act of
1934, as amended, and the rules and regulations promulgated thereunder.

Section 1.12 "Initial Closing" shall mean the closing as contemplated by
Article I of the Escrow Agreement.

Section 1.13 "Investment Amount" shall mean the dollar amount to be
invested by the Investor to purchase Put Shares with respect to any Put as
notified by the Company to the Investor in the Put Notice, all in accordance
with Section 2.2 hereof.

Section 1.14 "Material Adverse Effect" shall mean any effect on the
business, Bid Price, operations, properties or financial condition of the
Company that is material and adverse to the Company and its subsidiaries and
affiliates, taken as a whole, and/or any condition, circumstance, or situation
that would prohibit or otherwise interfere with the ability of the Company to
enter into and perform any of its obligations under this Agreement, the
Registration Rights Agreement or the Escrow Agreement in any material respect.

Section 1.15 "Maximum Put Amount" shall mean, as of the date of any Put
Notice, 4.5% of the weighted average price for the three (3) month period
immediately prior to the date of the Put Notice multiplied by the total trading
volume in respect of the Common Stock for the three (3) month period immediately
prior to the date of the Put Notice.

Section 1.16 "NASD" shall mean the National Association of Securities
Dealers, Inc.

Section 1.17 "Outstanding" when used with reference to shares of Common
Stock or Capital Shares (collectively the "Shares"), shall mean, at any date as
of which the number of such Shares is to be determined, all issued and
outstanding Shares, and shall include all such Shares issuable in respect of
outstanding scrip or any certificates representing fractional interests in such
Shares; provided, however, that "Outstanding" shall not mean any such Shares
then directly or indirectly owned or held by or for the account of the Company.


2
{PAGE}

Section 1.18 "Person" shall mean an individual, a corporation, a
partnership, a limited liability company, an association, a trust or other
entity or organization, including a government or political subdivision or an
agency or instrumentality thereof.

Section 1.19 "Principal Market" shall mean the NASDAQ National Market, the
NASDAQ SmallCap Market, the American Stock Exchange or the New York Stock
Exchange, whichever is at the time the principal trading exchange or market for
the Common Stock. Principal Market shall not include the OTC Bulletin Board
without the express written consent of the Investor.

Section 1.20 "Purchase Price" shall mean with respect to Put Shares,
eighty-six and one half percent (86.5%) (the "Purchase Price Percentage") of the
VWAP on each Trading Day during the Valuation Period related to a Put (or such
other date on which the Purchase Price is calculated in accordance with the
terms and conditions of this Agreement).

Section 1.21 "Put" shall mean each occasion the Company elects to exercise
its right to tender a Put Notice requiring the Investor to purchase shares of
the Company's Common Stock, subject to the terms of this Agreement.

Section 1.22 "Put Notice" shall mean a written notice to the Investor
setting forth the Investment Amount that the Company intends to sell to the
Investor in the form attached hereto as Exhibit B.

Section 1.23 "Put Shares" shall mean all shares of Common Stock or other
securities issued or issuable pursuant to a Put that has occurred or may occur
in accordance with the terms and conditions of this Agreement.

Section 1.24 "Registrable Securities" shall mean the Put Shares and the
Warrant Shares until (i) all Put Shares and Warrant Shares have been disposed of
pursuant to the Registration Statement, (ii) all Put Shares and Warrant Shares
have been sold under circumstances under which all of the applicable conditions
of Rule 144 (or any similar provision then in force) under the Securities Act
("Rule 144") are met, (iii) all Put Shares and Warrant Shares have been
otherwise transferred to persons who may trade such shares without restriction
under the Securities Act, and the Company has delivered a new certificate or
other evidence of ownership for such securities not bearing a restrictive legend
or (iv) such time as, in the opinion of counsel to the Company, all Put Shares
and Warrant Shares may be sold without any time, volume or manner limitations
pursuant to Rule 144(k) (or any similar provision then in effect) under the
Securities Act.

Section 1.25 "Registration Rights Agreement" shall mean the agreement
regarding the filing of the Registration Statement for the sale and resale of
the Registrable Securities annexed hereto as Exhibit C.

Section 1.26 "Registration Statement" shall mean a registration statement
on Form S-3 (if use of such form is then available to the Company pursuant to
the rules of the SEC and, if not, on such other form promulgated by the SEC,
such as Form S-1 or SB-2, for which the Company then qualifies and which counsel
for the Company shall deem appropriate, and which form shall be available for
the resale by the Investor of the Registrable Securities to be registered
thereunder in accordance with the provisions of this Agreement, the Registration
Rights Agreement, and in accordance with the intended method of distribution of
such securities), for the registration of the resale by the Investor of the
Registrable Securities under the Securities Act.


3
{PAGE}

Section 1.27 "SEC" shall mean the Securities and Exchange Commission.

Section 1.28 "Securities Act" shall mean the Securities Act of 1933, as
amended.

Section 1.29 "SEC Documents" shall mean the Company's latest Form 10-K or
10-KSB as of the time in question, all Forms 10-Q or 10-QSB and 8-K filed
thereafter, and the Proxy Statement for its latest fiscal year as of the time in
question until such time as the Company no longer has an obligation to maintain
the effectiveness of a Registration Statement as set forth in the Registration
Rights Agreement.

Section 1.30 "Threshold Price" is the lowest VWAP at which the Company
will sell its Common Stock with respect to any Trading Day within a Valuation
Period determined in its sole and absolute discretion in any Put Notice.

Section 1.31 "Trading Day" shall mean any day during which the Principal
Market shall be open for business.

Section 1.32 "Valuation Event" shall mean an event in which the Company at
any time prior to the end of the Commitment Period takes any of the following
actions:

(a) subdivides or combines its Common Stock;

(b) pays a dividend on its Capital Shares or makes any other
distribution of its Capital Shares;

(c) issues any additional Capital Shares ("Additional Capital
Shares"), otherwise than as provided in the foregoing Subsections (a) and (b)
above or (d) and (e) below, at a price per share less, or for other
consideration lower, than the Bid Price in effect immediately prior to such
issuance, or without consideration (other than pursuant to this Agreement);

(d) issues any warrants, options or other rights (other than
pursuant to the Company's employee benefit plan) to subscribe for or purchase
any Additional Capital Shares and the price per share for which Additional
Capital Shares may at any time thereafter be issuable pursuant to such warrants,
options or other rights shall be less than the Bid Price in effect immediately
prior to the issuance of the relevant warrants, options or other rights;

(e) issues any securities convertible into or exchangeable for
Capital Shares and the consideration per share for which Additional Capital
Shares may at any time thereafter be issuable pursuant to the terms of such
convertible or exchangeable securities shall be less than the Bid Price in
effect immediately prior to such issuance;

(f) makes a distribution of its assets or evidences of indebtedness
to the holders of its Capital Shares as a dividend in liquidation or by way of
return of capital or other than as a dividend payable out of earnings or surplus
legally available for dividends under applicable law or any distribution to such
holders made in respect of the sale of all or substantially all of the Company's
assets (other than under the circumstances provided for in the foregoing
subsections (a) through (e)); or

(g) takes any action affecting the number of Outstanding Capital
Shares, other than an action described in any of the foregoing Subsections (a)
through (f) hereof, inclusive, which in the opinion of the Company's Board of
Directors, determined in good faith, would have a Material Adverse Effect upon
the rights of the Investor at the time of a Put.


4
{PAGE}

Section 1.33 "Valuation Period" shall mean the period of twenty-two (22)
Trading Days beginning on the date specified in the Put Notice; provided,
however, that if a Valuation Event occurs during a Valuation Period, a new
Valuation Period shall begin on the Trading Day immediately after the occurrence
of such Valuation Event and end on the twenty-second (22nd) Trading Day
thereafter.

Section 1.34 "VWAP" shall mean the daily volume weighted average price of
the Company's Common Stock on the Principal Market as reported by Bloomberg
Financial L.P. (based on a trading day from 9:30 am EST to 4:00 pm EST) using
the VAP function.

Section 1.35 "Warrants" shall include (i) the 33,000 Common Stock Purchase
Warrants in the form of Exhibit D hereto to be delivered to the Investor at the
Initial Closing (the "Initial Warrants"), (ii) 1,000 Common Stock Purchase
Warrants in the form of Exhibit D hereto to be delivered to the Investor for
each $100,000 of Put Shares purchased by the Investor at each applicable
Settlement Date (the "Put Warrants) and (iii) a warrant certificate to purchase
up to a number of shares of Common Stock equal to 25% of the number of shares of
Common Stock purchased by the Investor on such Settlement Date pursuant to this
Agreement in the form attached hereto as Exhibit E (each a "Short Term
Warrant"); provided, however, in no event shall the Company issue more than
66,000 Initial Warrants and Put Warrants, in the aggregate, in connection with
this Agreement to the Investor. "Warrant Shares" shall mean the shares of Common
Stock issuable upon exercise of the Warrants.

ARTICLE II

Purchase and Sale of Common Stock

Section 2.1 Investments. Subject to the satisfaction of the conditions set
forth herein (including, without limitation, the provisions of Article VII
hereof), the parties agree as follows:

(a) Put Right. At any time during the Commitment Period, subject to
the conditions set forth in Section 7.2, the Company, may, in its sole
discretion, issue and exercise a Put, which Put the Investor will be obligated
to accept; provided, however, that the Investment Amount for each Put as
designated by the Company in the applicable Put Notice shall be neither less
than $250,000 per Put nor more than the Maximum Put Amount, except that, the
Company's final Put may be less than $250,000 if the Commitment Amount is less
than $250,000. Only one Put shall be allowed in each Valuation Period.

(b) Settlement Date. The price per share paid by the Investor shall
be the Purchase Price on each separate Trading Day during the Valuation Period.
The number of shares of Common Stock purchased by the Investor with respect to
each Put shall be determined on a daily basis during each Valuation Period and
settled on, (i) as to the 1st to the 11th Trading Days after a Valuation Period
commences, on the 13th Trading Day after a Valuation Period commences, and (ii)
as to the 12th to the 22nd Trading Days after a Valuation Period commences, the
24th Trading Day after a Valuation Period. (each, a "Settlement Date"). In
connection with each Valuation Period, the Company may set a Threshold Price, if
any, in the Put Notice. If the VWAP on any Trading Day within the Valuation
Period is less than the Threshold Price, the Company shall not sell and the

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC